阿凯迪亚生物科学 RKDA 深 沪
等待开盘 05-18 09:30:00 美东时间
0.9556
-0.114
-10.69%
华盛通- 最 高1.0694
- 今 开1.04
- 成交量 5.99万股
- 最 低 0.91
- 昨 收 1.07
- 总市值 196.56万
- 52周最高 6.71
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.89
- 委 比 -11.11%
- 总股本 205.69万
- 历史最高 7040.00
- 量 比 1.29
- 振 幅 14.90%
- 历史最低 0.89
- 每 手 1
- 风险率 1.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Arcadia Biosciences Q1 EPS $(2.11) Misses $(0.80) Estimate, Sales $1.100M Miss $1.600M Estimate
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.11) per share which missed the analyst consensus estimate of $(0.80) by 163.75 percent. This is a 211.05 percent decrease over earnings of $1.90 per
05-15 04:53
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
Arcadia Biosciences reported Q1 2026 results with Zola coconut water volumes up 18% YoY and SG&A at its lowest level as a public company. Despite a 8% revenue decline to $1.1M, the company remains focused on growing its Zola brand and launching new products. Operating expenses increased $1.2M, driven by higher costs and absence of prior year gains. Net loss widened to $4.4M, reflecting warrant inducement costs and other losses. Arcadia continues ...
05-14 20:05
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Gainers 22nd Century Gr (NASDAQ:XXII) shares moved upwards by 19.2% to $1.86 d...
05-01 20:05
Arcadia Biosciences Q4 EPS $(0.97) Misses $(0.66) Estimate, Sales $901.000K Miss $1.400M Estimate
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.66) by 46.97 percent. This is a 67.45 percent increase over losses of $(2.98) per share
03-27 04:15
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
<p>Arcadia Biosciences entered into definitive agreements to exercise preferred investment options, purchasing up to 808,595 shares at a reduced price of $2.575 per share. The offering is expected to generate approximately $2.1 million in gross proceeds, with H.C. Wainwright & Co. as the placement agent. New unregistered preferred investment options for up to 1,617,190 shares will be issued, exercisable at $2.325 per share. The proceeds will be u...
01-12 13:00
Arcadia Biosciences strategic review after merger termination
Arcadia Biosciences ( ($RKDA) ) just unveiled an announcement. On December 24, ...
2025-12-30 06:05
Arcadia Biosciences Gets Termination Notification Regarding Proposed Business Combination Deal With Roosevelt Resources
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating the
2025-12-26 21:04
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced that it received a notice from Roosevelt Resources, LP terminating their Securities Exchange Agreement dated December 4, 2024, regarding a proposed business combination. CEO T.J. Schaefer stated that Arcadia will resume evaluating strategic alternatives to create value for shareholders. Arcadia has streamlined operations, reduced expenses, and grown its Zola coconut water brand without using long...
2025-12-26 13:02
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
Gainers Maison Solutions (NASDAQ:MSS) stock moved upwards by 7.5% to $0.4 duri...
2025-12-25 05:05
